company background image
CL logo

Cresco Labs CNSX:CL Stock Report

Last Price

CA$2.78

Market Cap

CA$1.4b

7D

-6.4%

1Y

28.1%

Updated

28 Mar, 2024

Data

Company Financials +

CL Stock Overview

Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States.

CL fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Cresco Labs Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Cresco Labs
Historical stock prices
Current Share PriceCA$2.78
52 Week HighCA$3.78
52 Week LowCA$1.35
Beta2.06
1 Month Change15.83%
3 Month Change55.31%
1 Year Change28.11%
3 Year Change-82.60%
5 Year Change-83.78%
Change since IPO-57.56%

Recent News & Updates

Cresco Labs Inc. (CSE:CL) Released Earnings Last Week And Analysts Lifted Their Price Target To CA$5.41

Mar 16
Cresco Labs Inc. (CSE:CL) Released Earnings Last Week And Analysts Lifted Their Price Target To CA$5.41

Recent updates

Cresco Labs Inc. (CSE:CL) Released Earnings Last Week And Analysts Lifted Their Price Target To CA$5.41

Mar 16
Cresco Labs Inc. (CSE:CL) Released Earnings Last Week And Analysts Lifted Their Price Target To CA$5.41

Investors Don't See Light At End Of Cresco Labs Inc.'s (CSE:CL) Tunnel And Push Stock Down 32%

Mar 03
Investors Don't See Light At End Of Cresco Labs Inc.'s (CSE:CL) Tunnel And Push Stock Down 32%

Cresco Labs (CSE:CL) Seems To Be Using A Lot Of Debt

Jan 26
Cresco Labs (CSE:CL) Seems To Be Using A Lot Of Debt

Risks To Shareholder Returns Are Elevated At These Prices For Cresco Labs Inc. (CSE:CL)

Jan 04
Risks To Shareholder Returns Are Elevated At These Prices For Cresco Labs Inc. (CSE:CL)

Is Cresco Labs (CSE:CL) Using Too Much Debt?

Sep 22
Is Cresco Labs (CSE:CL) Using Too Much Debt?

Some Confidence Is Lacking In Cresco Labs Inc. (CSE:CL) As Shares Slide 33%

Aug 11
Some Confidence Is Lacking In Cresco Labs Inc. (CSE:CL) As Shares Slide 33%

Cresco Labs (CSE:CL) Has A Somewhat Strained Balance Sheet

Jan 25
Cresco Labs (CSE:CL) Has A Somewhat Strained Balance Sheet

Are Investors Undervaluing Cresco Labs Inc. (CSE:CL) By 24%?

Dec 13
Are Investors Undervaluing Cresco Labs Inc. (CSE:CL) By 24%?

We Think Cresco Labs (CSE:CL) Is Taking Some Risk With Its Debt

Aug 22
We Think Cresco Labs (CSE:CL) Is Taking Some Risk With Its Debt

Estimating The Intrinsic Value Of Cresco Labs Inc. (CSE:CL)

May 23
Estimating The Intrinsic Value Of Cresco Labs Inc. (CSE:CL)

Cresco Labs Inc. (CSE:CL) Analysts Are Way More Bearish Than They Used To Be

Mar 24
Cresco Labs Inc. (CSE:CL) Analysts Are Way More Bearish Than They Used To Be

Estimating The Fair Value Of Cresco Labs Inc. (CSE:CL)

Feb 02
Estimating The Fair Value Of Cresco Labs Inc. (CSE:CL)

Cresco Labs Inc. (CSE:CL) Shares Could Be 41% Below Their Intrinsic Value Estimate

Oct 27
Cresco Labs Inc. (CSE:CL) Shares Could Be 41% Below Their Intrinsic Value Estimate

Cresco Labs (CSE:CL) Takes On Some Risk With Its Use Of Debt

Oct 06
Cresco Labs (CSE:CL) Takes On Some Risk With Its Use Of Debt

Cresco Labs Inc. (CSE:CL) Just Reported Annual Earnings And Analysts Are Lifting Their Estimates

Mar 27
Cresco Labs Inc. (CSE:CL) Just Reported Annual Earnings And Analysts Are Lifting Their Estimates

Shareholder Returns

CLCA PharmaceuticalsCA Market
7D-6.4%4.6%0.5%
1Y28.1%45.8%8.7%

Return vs Industry: CL underperformed the Canadian Pharmaceuticals industry which returned 48.8% over the past year.

Return vs Market: CL exceeded the Canadian Market which returned 9% over the past year.

Price Volatility

Is CL's price volatile compared to industry and market?
CL volatility
CL Average Weekly Movement15.9%
Pharmaceuticals Industry Average Movement13.3%
Market Average Movement8.7%
10% most volatile stocks in CA Market18.3%
10% least volatile stocks in CA Market3.1%

Stable Share Price: CL's share price has been volatile over the past 3 months.

Volatility Over Time: CL's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of Canadian stocks.

About the Company

FoundedEmployeesCEOWebsite
19902,760Charlie Bachtellhttps://www.crescolabs.com

Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections and fruit-forward gummies under the Mindy’s Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts.

Cresco Labs Inc. Fundamentals Summary

How do Cresco Labs's earnings and revenue compare to its market cap?
CL fundamental statistics
Market capCA$1.36b
Earnings (TTM)-CA$237.73m
Revenue (TTM)CA$1.02b

0.9x

P/S Ratio

-4.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CL income statement (TTM)
RevenueUS$756.06m
Cost of RevenueUS$393.69m
Gross ProfitUS$362.37m
Other ExpensesUS$537.89m
Earnings-US$175.52m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.50
Gross Margin47.93%
Net Profit Margin-23.22%
Debt/Equity Ratio96.2%

How did CL perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.